Subhayan Sur

8PUBLICATIONS
10CO-AUTHORS
Molecular targetsPredictive and prognostic markersStructural properties of condensed matterEpigenetics (incl. genome methylation and epigenomics)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 14, 2026
Pratenol B, Eriodictyol, Losbanine, and Isookanin, as potential EGFR and HRAS inhibitors in oral squamous cell carcinoma.

|May 16, 2026
Circulating lncRNA as Biomarkers and Therapeutics in Oral Cancer: Silent Scripts with Loud Impact.

|May 14, 2026
Novel cuproptosis related long non-coding RNA signature in oral squamous cell carcinoma prognosis and immunotherapy.

|Mar 28, 2025
Emerging role and clinical applications of circular RNAs in human diseases.

Subhayan Sur, Jayanta K Pal, Soumya Shekhar

|Oct 18, 2024
Clinical implications of miRNAs in erythropoiesis, anemia, and other hematological disorders.

Jayanta Kumar Pal, Subhayan Sur, Smriti P K Mittal

|Feb 05, 2024
Momordicine-I Suppresses Head and Neck Cancer Growth by Reprogrammimg Immunosuppressive Effect of the Tumor-Infiltrating Macrophages and B Lymphocytes.

Subhayan Sur, Pradeep Bhartiya, Robert Steele

Pageof 2

Frequent Collaborators

3 joint publications

Jayanta Kumar Pal

1 joint publications

Saurabh Dey

1 joint publications

Bini Biswas

1 joint publications

Soumya Basu